Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunological effects and safety of live rotavirus vaccination after antenatal exposure to immunomodulatory biologic agents: a prospective cohort study from the Canadian Immunization Research Network
Tiffany Fitzpatrick, Khaled Alsager, Manish Sadarangani, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 9, pp. 648-656
Closed Access | Times Cited: 24

Showing 24 citing articles:

Updates on the management of inflammatory bowel disease from periconception to pregnancy and lactation
Ole Haagen Nielsen, John Gubatan, Kaija‐Leena Kolho, et al.
The Lancet (2024) Vol. 403, Iss. 10433, pp. 1291-1303
Closed Access | Times Cited: 15
Infant Ustekinumab Clearance, Risk of Infection, and Development After Exposure During Pregnancy
Mette Julsgaard, Jantien W. Wieringa, Simon Mark Dahl Baunwall, et al.
Clinical Gastroenterology and Hepatology (2024)
Open Access | Times Cited: 6
Mannan-Decorated Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Antitumor Immune Response by Modulating the Tumor Microenvironment
Liusheng Wu, Lei Yang, Xinye Qian, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 8, pp. 229-229
Open Access | Times Cited: 5
The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy management
Ian Giles, Iona Thorne, Nanna Surlemont Schmidt, et al.
The Lancet Rheumatology (2024) Vol. 6, Iss. 8, pp. e546-e559
Closed Access | Times Cited: 3
Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero
Ralley Prentice, Emma Flanagan, Emily K. Wright, et al.
Clinical Gastroenterology and Hepatology (2024)
Closed Access | Times Cited: 3
Navigating Reproductive Care in Patients With Inflammatory Bowel Disease: A Comprehensive Review
Paula Sousa, Javier P. Gisbert, Mette Julsgaard, et al.
Journal of Crohn s and Colitis (2024) Vol. 18, Iss. Supplement_2, pp. ii16-ii30
Open Access | Times Cited: 3
Normal infant immunologic assessment and uneventful live rotavirus vaccination despite continuous tofacitinib exposure in-utero and during breastfeeding
Kenneth Ernest-Suárez, Luis Murguía-Favela, Kerri L. Novak, et al.
Crohn s & Colitis 360 (2024)
Open Access | Times Cited: 2
The Fundamentals of Inflammatory Bowel Disease Management in Pregnancy: A Practical Review for the Gastroenterologist
Elizabeth Squirell, Susanna Meade, Yvette Leung
Journal of the Canadian Association of Gastroenterology (2024) Vol. 7, Iss. 1, pp. 121-131
Open Access | Times Cited: 1
The outcomes of children born to mothers with autoimmune rheumatic diseases
Laura Andréoli, Jeanette Andersen, Tadej Avčin, et al.
The Lancet Rheumatology (2024) Vol. 6, Iss. 8, pp. e573-e586
Closed Access | Times Cited: 1
Ustekinumab and Vedolizumab Safety and Clearance in Pregnancy with Inflammatory Bowel Disease: Stop the Disease, not the Drug!
Joana Torres, Uma Mahadevan
Clinical Gastroenterology and Hepatology (2024)
Open Access | Times Cited: 1
Live Rotavirus Vaccination Appears Low-risk in Infants Born to Mothers With Inflammatory Bowel Disease on Biologics
Kenneth Ernest-Suárez, Luis Murguía-Favela, Cora Constantinescu, et al.
Clinical Gastroenterology and Hepatology (2024)
Open Access | Times Cited: 1
Common Mistakes in Managing Patients with Inflammatory Bowel Disease
Javier P. Gisbert, María Chaparro
(2024)
Open Access | Times Cited: 1
Safety of Rotavirus Vaccination in Infants That Were Exposed to Biologics In Utero: A Systematic Review
Trevor L. Schell, Lucas Fass, Mary Hitchcock, et al.
Inflammatory Bowel Diseases (2024)
Closed Access | Times Cited: 1
What Should We Know about Drugs Levels and Therapeutic Drug Monitoring during Pregnancy and Breastfeeding in Inflammatory Bowel Disease under Biologic Therapy?
M Barrau, Xavier Roblin, Leslie Andromaque, et al.
(2023)
Open Access | Times Cited: 3
What Should We Know about Drug Levels and Therapeutic Drug Monitoring during Pregnancy and Breastfeeding in Inflammatory Bowel Disease under Biologic Therapy?
Mathilde Barrau, Xavier Roblin, Leslie Andromaque, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7495-7495
Open Access | Times Cited: 2
Infliximab

Reactions Weekly (2024) Vol. 2003, Iss. 1, pp. 468-468
Closed Access
Immunization and Other Considerations in Immunocompromised Children

(2024), pp. 93-109
Closed Access
Serological responses to vaccination in children exposed in utero to ustekinumab or vedolizumab: cross-sectional analysis of a prospective multicentre cohort
Katarína Mitrová, Karin Černá, Kristýna Zdychyncová, et al.
European Journal of Pediatrics (2024) Vol. 183, Iss. 10, pp. 4243-4251
Open Access
Common Mistakes in Managing Patients with Inflammatory Bowel Disease
Javier P. Gisbert, María Chaparro
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4795-4795
Open Access
Low Placental Transfer Rates of Risankizumab Among Pregnant Women With Inflammatory Bowel Disease
Uma Mahadevan, Millie D. Long
Inflammatory Bowel Diseases (2024)
Closed Access
Inflammatory Bowel Disease and Reproductive Health: A Focus on Pregnancy Planning and Outcomes
Sahaj Mujumdar, Michelle D'Souza, Maisa Abdalla
Seminars in Reproductive Medicine (2024)
Closed Access
Case report: Ulcerative colitis-related spondyloarthritis treated with golimumab until 27 weeks of gestation
R. Okazaki, Ikkou Hirata, Hiroshi Ikegami, et al.
Obstetric Medicine (2024)
Closed Access
Validation of the Pharmacokinetic Model for Anti-TNFα Clearance in Infants Exposed to Anti-TNFα During Pregnancy
Jantien W. Wieringa, Matthijs D. Kruizinga, Gertjan J. Driessen, et al.
Journal of Crohn s and Colitis (2023) Vol. 18, Iss. 4, pp. 506-515
Closed Access | Times Cited: 1
Rotavirus-Lebendimpfung nach vorgeburtlicher Biologika-Exposition
Judith Lorenz
Pädiatrie up2date (2023) Vol. 18, Iss. 04, pp. 274-274
Closed Access
Page 1

Scroll to top